- And… We’re Back.
- Transitions
- Bioethical Marching Orders
- FDA Intervention Shelves Plan for Drugstore Genome Tests
- The Boons of an NIH Boost
- Crime Lab DNA Databases Under the Microscope
- Domes of Carbon Over U.S. Cities Damage Urban Health
- FDA Rules for Cigarettes Are a Victory for Public Health, for Science (and for the Earth’s Climate?)
- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
“Scientist In Chief”: $5 Billion in Recovery Funds Support Biomedicine, Create Jobs
“We are very grateful to have a president who respects science,” said Director Francis Collins this morning, addressing staff and leaders of the National Institutes of Health. Collins was introducing the man he referred to as “our scientist in chief,” Barack Obama.
The president paid a visit to the NIH campus in Bethesda to announce what officials hinted at a few weeks ago: the agency has so far distributed $5 billion in American Recovery and Reinvestment Act funds. As of today, that means that the ARRA has funded more than 12,000 projects, and 1,800 of those grants have gone to researchers who have never before gotten a major NIH award, according to Collins.
According to a video posted posted on the White House blog, NIH estimates that the $10.4 billion in Recovery Act funds will support approximately 50,000 jobs. In his speech today, Collins said the new funds have gone to “some of the most innovative and creative directions for research that I have seen in 16 years at NIH” and that the galaxy of new grants “is not just about ‘doubling the recipe.’”
Obama emphasized the dual benefits of the “the single largest boost to biomedical research in history”: advances in treatments for life-threatening diseases and job creation. He pointed specifically to projects aimed at cancer, heart disease, and autism research.
Remarks from the director and president are available via streaming video; the Washington Post has a transcript of the president’s speech. (HT: Jocelyn Kaiser at ScienceInsider)
Comments on this article
